Common gynecologic tumors including ovarian cancer, endometrial cancer, cervical cancer, and fallopian tube cancer often have their ovaries removed after surgical treatment (unless there are patients who require preservation of reproductive function). Or some breast cancer patients with anti-estrogen therapy often develop perimenopausal syndrome, commonly known as menopause syndrome, which becomes one of the main clinical problems that plague patients. Female menopause generally occurs at the age of 45-50 years with an incidence of more than 80%, more than 30% in severe cases, and up to 100% in patients with ovariectomized gynecologic tumors. However, due to the long-standing lack of awareness of the seriousness of the disease, many patients do not actively seek medical advice because they consider it a normal physiological reaction, resulting in many patients not receiving effective treatment. The performance of these patients have body hot flashes sweating palpitations frequent urination loss of libido poor sleep poor osteoporosis and other very poor some patients are also complicated by emotional instability very difficult poor memory suspicious irritability, depression, etc. If not timely intervention, directly affect their mood, diet, sleep quality, leading to a decline in immunity, a few people even appear menopausal depression, produce light thoughts, to individuals, families and society has brought a certain adverse impact. In addition, long-term insomnia and emotional abnormalities can lead to the decrease of human immune function, which increases the risk of gynecological tumor recurrence and metastasis. Especially for patients before 45 years old, the symptoms occurring after ovariectomy are more obvious and not tolerated. This is because estrogen levels in these patients are suddenly reduced without a gradual adaptation process. The essence of this disease is a series of syndromes caused by low estrogen levels, mainly metabolic disorders of phytonadism. For menopausal syndrome occurring in non-oncology patients, conventional therapy is estrogen replacement therapy, or estrogen combined with progestin or androgen therapy, which has some therapeutic effect. However, on July 9, 2002, the National Institutes of Health (NIH) Heart, Lung, and Blood Institute announced that the Women’s Health Initiation Initiative (WHI) clinical trial of estrogen plus progestin in healthy postmenopausal women was terminated early due to a 26% increased relative risk of breast cancer and no overall benefit (Rossouw, J. E. et al. J. Am. Med. Assoc. 288, 321-333 (2002). ), the incidence of breast cancer in the United States dropped dramatically by 6% in 2003. This is an important evidence-based study that confirms that the overall effect of estrogen replacement therapy outweighs the benefits. This will have a significant impact on future HRT in postmenopausal women. More importantly, estrogen is a contraindication for estrogen-dependent tumors (most gynecologic tumors are estrogen-dependent) and its use may promote tumor recurrence and metastasis. In addition, patients with severe hypertension and diabetes mellitus on Fridays are also contraindicated. Therefore, a large number of patients cannot receive effective treatment. Chinese medicine has accumulated a wealth of experience in treating this disease. Therefore, Chinese medicine is expected to replace or supplement the therapeutic effect of HRT on menopausal syndrome and minimize the side effects caused by using HRT exclusively. Chinese medicine believes that this disease occurs mainly due to deficiency of kidney qi, which in turn leads to exuberant liver fire and inflammation of heart fire. Among them, the generally accepted view is that the kidney qi is deficient, therefore, the clinical treatment based on kidney tonification is also the most widely accepted. Based on the unique physical characteristics of gynecologic tumor patients, I myself believe that combined with the age and physical characteristics of gynecologic tumor patients, they are mainly divided into two categories: kidney deficiency type and liver fire type, according to which effective formulas are made to treat this disease with very significant results. The main clinical symptoms of patients can be effectively improved in a very short time, such as hot flashes, night sweats and irritability. In addition, because the treatment of gynecological tumor patients should pay attention to the combination of the treatment of tumor itself, the treatment of preventing recurrence and metastasis and the treatment of menopause, which is the most different point from the treatment of other menopausal syndrome patients. The diet of gynecological tumor patients with menopausal syndrome is forbidden to eat chicken, sea shrimp, crab, dog meat, mutton, scallop, bee milk, royal jelly and white wine. The patient should pay attention to his own heart regulation, appropriate outdoor activities such as tai chi, listen to more light music, and cultivate appropriate personal hobbies, all of which can achieve the purpose of reducing symptoms.